Biologics in Focus: Legal and Business Strategies for Success in Evolving and Complex Technologies

Please join Morrison Foerster and Bayer Co.Lab for a four-part series exploring legal and business aspects of biologics, including cell and gene therapies. Sessions will be held virtually via webinar. The last session, however, has the option for in-person attendance, which will be followed by a reception. Please use the separate link to reserve your space.

Biologics in Focus: Legal and Business Strategies for Success in Evolving and Complex Technologies

Topics covered will include:

• Operating in a Crowded Landscape: Freedom to Operate and Licensing in Cell & Gene Therapies
  
  Monday, October 21 (12:00 p.m. – 1:00 p.m. ET)
  
  Speakers: Karen Potter and Matt Karlyn
  
  This presentation will give an initial overview of the cell and gene therapy market and how to navigate an increasingly crowded IP landscape and market. Our experts will cover topics including:
• A review of the IP landscape and freedom to operate considerations focusing on emerging technologies in the cell and gene therapy space.  
• Key terms and considerations for licensing geneediting technologies including CRISPR-Cas systems and alternative gene editing systems. 
• Venture Financing and M&A in Biologics
  
  Tuesday, October 29 (12:00 p.m. – 1:00 p.m. ET)
  
  Speakers: Jim Krenn, Shai Kalansky, and Alex Okuliar
  
  Our in-depth legal webinar continues as we explore the dynamic landscape of venture financing and mergers & acquisitions (M&A) in the biologics sector, with a special focus on cell and gene therapies. As these innovative treatments continue to transform patient care, understanding the financial and regulatory frameworks is crucial for legal professionals, investors, and biotech companies. This presentation will provide valuable insight, including insight into:
• Overview of funding for cell and gene therapy companies, such as analysis of recent investment trends and deal structures and terms, among other key criteria.
• M&A Landscape in Biologics, such as deal activity, legal and antitrust considerations and challenges in negotiating deals, and emerging opportunities and potential pitfalls.
• Cell and Gene Therapy Collaborations
  
  Tuesday, November 12 (12:00 p.m. – 1:00 p.m. ET)
  
  Speakers: Brigid Bondoc and Matthew Ferry
  
  
  Our next presentation continues to unfold the biologics landscape with a focus on the specific regulatory and collaboration considerations for cell and gene therapies. This presentation will cover:
• An overview of the regulatory framework for biological products (the category of FDA-regulated products to which cell and gene therapies belong), including key definitions and concepts and expedited review
• Essential considerations for collaborations involving cell and gene therapies, including resulting IP, supply chain management, and common financial frameworks.

• Protecting and Enforcing Biologics IP
  
  Tuesday, November 19 (4:00 p.m. – 5:00 p.m. ET)
  
  Speakers: Meghan Poon and Alyssa Monsen
  
  Register for in-person attendance to the November 19 session.
  
  For our final presentation, we encourage you to attend in-person at Bayer Co.Lab’s office in Cambridge, MA, followed by an in-person reception. It will be a fantastic opportunity for networking, great food, and fun prizes. For those who can’t attend, the presentation is still available via the Zoom registration.
  
  For the final part of our series, we will focus on the protection and enforcement of intellectual property (IP) in biologics. As innovation in biologics accelerates, understanding the complexities of IP law is crucial for biotech companies and legal professionals alike. This presentation will touch on:
• Patent drafting and prosecution strategies to build a litigation-ready patent portfolio in the biologics space.
• Common litigation issues and strategies for enforcement against biosimilars and competitors.

Prizes will be awarded to individuals attending all four sessions!

Space for these events is limited. To register your interest, please use the RSVP buttons.